NetScientific Release: Capital Markets Day
London, UK – 15 May 2015 – NetScientific plc (AIM: NSCI), the biomedical and healthcare technology group, is holding a Capital Markets Day for institutional investors and analysts today in London.
The event includes a presentation on NetScientific’s refined strategy which has been under review since the full year results in March. In summary, the strategy is to fund, develop and manage early and mid-stage healthcare technology companies sourced from strategic partnerships and relationships in the USA and UK. The primary focus will remain on digital health, diagnostics and therapeutics. These sectors represent highly attractive growth markets where breakthrough technology solutions are in high demand. The Group will be concentrating on its five lead companies and further strengthening its strategic relationships with partners such as Breakout Labs, to build a unique transformative portfolio. There will also be presentations from key companies in the portfolio. A copy of the presentations from the day will be made available on the website: www.netscientific.net.
No new information will be disclosed during the Capital Markets Day.
- ENDS -
Notes To Editors
About NetScientific
NetScientific is a biomedical and healthcare technology group that funds and develops technologies that offer transformative benefits to people's lives and society through improved diagnosis, prognosis and treatment. For more information, please visit the website at www.netscientific.net.
Issued for and on behalf of NetScientific by Instinctif Partners.
For more information please contact:
NetScientific
Peter Thoms, CFOTel:
+44 (0)77 2055 5752
Investec
Gary Clarence / Daniel Adams
Tel: +44 (0)20 7597 4000
Instinctif Partners
Melanie Toyne-Sewell / Jayne Crook
Tel: +44 (0)20 7457 2020
Email: netscientific@instinctif.com
Help employers find you! Check out all the jobs and post your resume.
The event includes a presentation on NetScientific’s refined strategy which has been under review since the full year results in March. In summary, the strategy is to fund, develop and manage early and mid-stage healthcare technology companies sourced from strategic partnerships and relationships in the USA and UK. The primary focus will remain on digital health, diagnostics and therapeutics. These sectors represent highly attractive growth markets where breakthrough technology solutions are in high demand. The Group will be concentrating on its five lead companies and further strengthening its strategic relationships with partners such as Breakout Labs, to build a unique transformative portfolio. There will also be presentations from key companies in the portfolio. A copy of the presentations from the day will be made available on the website: www.netscientific.net.
No new information will be disclosed during the Capital Markets Day.
- ENDS -
Notes To Editors
About NetScientific
NetScientific is a biomedical and healthcare technology group that funds and develops technologies that offer transformative benefits to people's lives and society through improved diagnosis, prognosis and treatment. For more information, please visit the website at www.netscientific.net.
Issued for and on behalf of NetScientific by Instinctif Partners.
For more information please contact:
NetScientific
Peter Thoms, CFOTel:
+44 (0)77 2055 5752
Investec
Gary Clarence / Daniel Adams
Tel: +44 (0)20 7597 4000
Instinctif Partners
Melanie Toyne-Sewell / Jayne Crook
Tel: +44 (0)20 7457 2020
Email: netscientific@instinctif.com
Help employers find you! Check out all the jobs and post your resume.